Social anxiety in a multiple sclerosis clinic population

Abstract

Background

Little is known about social anxiety in MS.

Objective

We estimated the prevalence of social anxiety symptoms and their association with demographic and clinical features in a clinic-attending sample of patients with MS.

Methods

Patients attending the Dalhousie MS Research Unit for regularly scheduled visits completed the Social Phobia Inventory (SPIN), the Hospital Anxiety and Depression Scale (HADS), and the Health Utilities Index (HUI). Neurological disability was determined by ratings on the Expanded Disability Status Scale (EDSS).

Results

A total of 251 patients completed self-report scales of anxiety and depression symptoms. In all, 245 (98%) provided sufficient data for analysis. In all, 30.6% (n = 75) had clinically significant social anxiety symptoms as defined by a SPIN threshold score of 19. Half of those with social anxiety had general anxiety (HADSA ≥ 11) and a quarter had depression (HADSD ≥ 11). Severity of social anxiety symptoms was associated with reduced health-related quality of life and not related to neurological disability.

Conclusions

Social anxiety symptoms are common in persons with MS, contribute to overall morbidity, but are unrelated to the overall severity of neurologic disability. Greater awareness and routine systematic inquiry of social anxiety symptoms is an important component of comprehensive care for persons with MS.

Keywords

depression generalized anxiety health-related quality of life multiple sclerosis social anxiety social phobia inventory symptoms

Get full access to this article

View all access options for this article.

References

1 Rogers J Bland R . Psychiatric manifestations of multiple sclerosis: a review. Can J Psychiatry 1996; 41: 441–445.

2 Feinstein A . The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2004; 49: 157–163.

3 Siegert RJ Abernethy DA . Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76: 469–475.

4 Korostil M Feinstein A . Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007; 13: 67–72.

5 Galeazzi GM Ferrari S Giaroli G . Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005; 26: 255–262.

6 Janssens AC van Doorn PA de Boer JB . Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003; 9: 397–403.

7 Smith SJ Young CA . The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil 2000; 14: 50–54.

8 Feinstein A O’Connor P Gray T Feinstein K . The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 1999; 5: 323–326.

9 Feinstein A . An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002; 59: 674–678.

10.

10 America Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Text Revision; 2000. P. 450–456.

11.

11 Shields M . Social anxiety disorder-beyond shyness. In: Statistics Canada catalogue 82-003, supplement to health reports. 2004; 15: 47–81.

12.

12 Cramer V Torgersen S Kringlen E . Quality of life and anxiety disorders: a population study. J Nerv Ment Dis 2005; 193: 196–202.

13.

13 Nova Scotia Department of Health. Social Anxiety in Nova Scotia. Canadian Community Health Survey Cycle 1.2 Report 2; June 2004.

14.

14 Gündel H Wolfe A Xidara V Busch R Ceballos-Baumann AO . Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry 2001; 71: 499–504.

15.

15 Moutier CY Stein MB . The history, epidemiology, and differential diagnosis of social anxiety disorder. J Clin Psychiatry 1999; 60(Suppl. 9): 4–8.

16.

16 Oberlander EL Schneier FR Liebowitz MR . Physical disability and social phobia. J Clin Psychopharmacol 1994; 14: 136–143.

17.

17 Stein MB Heuser IJ Juncos JL Uhde TW . Anxiety disorders in patients with Parkinson’s disease. Am J Psychiatry 1990; 147: 217–220.

18.

18 Schneier FR Barnes LF Albert SM Louis ED . Characteristics of social phobia among persons with essential tremor. J Clin Psychiatry 2001; 62: 367–372.

19.

19 Polman CH Reingold SC Edan G . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005; 58: 840–846.

20.

20 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

21.

21 Feeney DH Torrance GW Furlong WJ . Health utilities index. In: B Spilker , (ed), Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven Pub; 1996. P. 239–252.

22.

22 Fisk JD Brown MG Sketris IS Metz LM Murray TJ Stadnyk KJ . A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005; 76: 58–63.

23.

23 Connor KM Davidson JR Churchill LE Sherwood A Foe E Weisler RH . Psychometric properties of the Social Phobia Inventory (SPIN). Br J Psychiatry 2000; 176: 379–386.

24.

24 Antony MM Coons MJ McCabe RE Ashbaugh A Swinson RP . Psychometric properties of the social phobia inventory: further evaluation. Behav Res Ther 2006; 44: 1177–1185.

25.

25 Zigmond AS Snaith RP . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.

26.

26 Lester K Stepleman L Hughes M . The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 2007; 30: 177–186.

27.

27 Hakim EA Bakheit AM Bryant TN . The social impact of multiple sclerosis–a study of 305 patients and their relatives. Disabil Rehabil 2000; 22: 288–293.

28.

28 Dhalla S Kopec JA . The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med 2007; 30: 33–41.

29.

29 Ewing JA . Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905–1907.

30.

30 McCabe MP . Mood and self-esteem of persons with multiple sclerosis following an exacerbation. J Psychosom Res 2005; 59: 161–166.

31.

31 Poulin C Webster I Single E . Alcohol disorders in Canada as indicated by the CAGE questionnaire. CMAJ 1997; 157: 1543–1545.

32.

32 Katzelnick DJ Kobak KA DeLeire T . Impact of generalized social anxiety disorder in managed care. Am J Psychiatry 2001; 158: 1999–2007.

33.

33 Buckner JD Eggleston AM Schmidt NB . Social anxiety and problematic alcohol consumption: the mediating role of drinking motives and situations. Behav Ther 2006; 37: 381–391.